KOE:060280

Curexo Inc. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:41 UTC

Last close

n/aKRW

Market data

97.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
2.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
3.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-18.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.01Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

Price is the furthest below its sector's middle: 0.19 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

248

2016-12-31 to 2025-12-31100 at the start248

Sales: 100.00 on 2016-12-31 to 247.98 on 2025-12-31, up 148%.

Profit

11.5

2016-12-31 to 2025-12-31100 at the start11.5

Profit: 100.00 on 2016-12-31 to 11.53 on 2025-12-31, down 88%.

Shares in issue

147

2016-12-31 to 2025-12-31100 at the start147

Shares in issue: 100.00 on 2016-12-31 to 147.06 on 2025-12-31, up 47%.

Sales is at 248, Profit is at 12, Shares in issue is at 147, against 100 in 2016.

Sales is at 248, Profit is at 12, Shares in issue is at 147, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100248
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Profit, where the first year is 10012
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Shares in issue, where the first year is 100147
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW